Maribel Ramos remains cancer-free after taking part in a clinical trial led by breast cancer experts like Dr. Sylvia Adams at Perlmutter Cancer Center.
Photo: 嘿嘿视频 Staff
In 2016, Maribel Ramos enrolled in a clinical trial at 嘿嘿视频 Health鈥檚 Perlmutter Cancer Center that was testing an experimental treatment for triple-negative breast cancer, an aggressive form of the disease that doesn鈥檛 respond well to standard treatments. Within a few months of receiving a combination of immunotherapy and chemotherapy, Ms. Ramos鈥檚 tumors began to shrink, and eventually, her cancer became undetectable. Five years later she remains cancer-free.
Ms. Ramos, who is continuing to do well with her cancer under control, has remained on the immunotherapy regimen, says her oncologist Franco M. Muggia, MD, a professor in the and a member of Perlmutter Cancer Center.
Sylvia Adams, MD, a professor of medicine and director of the Breast Cancer Center at Perlmutter Cancer Center, tells SurvivorNet, 鈥淭he trial treatment was very successful for Maribel, and she continues on the same immunotherapy regimen indefinitely, without the chemotherapy component.鈥
鈥淲hen long-term treatment is needed, the importance of teamwork becomes readily apparent,鈥 Dr. Muggia says. 鈥淭he patient is part of the team, as are our colleagues and clinical research staff that refine and share information on the treatment regimens, the IV treatment unit staff, and lastly our nursing and office staff, who ensure trust and continuity of care.鈥
Read more from .
